Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$0.15 - $0.63 $1,305 - $5,481
-8,700 Reduced 33.46%
17,300 $3,000
Q3 2022

Jan 12, 2023

SELL
$0.52 - $3.08 $13,520 - $80,080
-26,000 Reduced 50.0%
26,000 $17,000
Q1 2022

May 02, 2022

BUY
$3.54 - $8.3 $35,400 - $83,000
10,000 Added 23.81%
52,000 $210,000
Q3 2021

Oct 25, 2021

BUY
$12.22 - $21.28 $513,240 - $893,760
42,000 New
42,000 $811,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Mbl Wealth, LLC Portfolio

Follow Mbl Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbl Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbl Wealth, LLC with notifications on news.